Seeking better outcomes for patients

CytRx Corporation is a biopharmaceutical company focused on the discovery and development of new therapeutics to treat patients with high unmet medical needs

Learn More

CytRx has potential milestone/royalty payments and an oncology subsidiary, Centurion BioPharma

CytRx milestones and royalties from Orphazyme for Arimoclomol​

Orphazyme preparing for commercialization in 2022 for arimoclomol​

CytRx potential milestones and royalties from ImmunityBio for aldoxorubicin ​

CytRx partnered Pipeline ​ with ImmunityBio - aldoxorubicin​